CHICAGO, April 12, 2016 -- The Kevin J. Lederer Life Foundation, a Chicago non-profit founded to help those with infertility, has announced their 2016 Life Grants program. The Life Foundation offers Life Grants to eligible individuals and couples to help defray the financial challenges of infertility treatment, adoption or third party reproduction.
Applications for the 2016 Life Grants will be accepted online at www.lifefindsaway.org/grants from April 24 through May 22, 2016.
The Life Foundation provides grants of financial assistance or donated services. Eligible applicants must reside in Illinois, Indiana or Wisconsin, and must have received a certified diagnosis of infertility. Exceptions include applicants who are single, or part of a same sex couple, and applicants applying for a grant for egg freezing for medical reasons. Applicants must have an annual household income of less than $110,000. Grants are awarded on an annual basis, and the amount of the grants, or total number of grants awarded each year is dependent upon fundraising. Grant requests may not exceed $10,000.
The Life Foundation is a collaborative foundation of medical practices, attorneys and third party agencies that assist in family building.
“It’s a privilege to help others achieve their dreams of parenthood,” says Life Foundation Board Member Lisa Rinehart, a reproductive health attorney and healthcare consultant.
“The costs of adoption or fertility treatment can be a struggle,” says Dr. Eve Feinberg, President and Director of the Life Foundation and Physician Partner at Fertility Centers of Illinois. “Through the Life Grants, we hope to ease the financial burden for those who want to have a family of their own.”
In 2015, the Life Foundation received 85 grant applications and awarded 12 grants. The foundation is supported by the following partners: Advanced Fertility Center of Chicago, Advanced Reproductive Center, Center for Reproductive Health, Fertility Centers of Illinois, InVia Fertility, IVF1 and the Reproductive Medicine Institute, along with Ballard, Desai & Miller and Conceive Abilities.
About The Kevin J. Lederer Life Foundation:
The Kevin J. Lederer Life Foundation (“Life Foundation”) is a collaborative, independent Chicago-based non-profit founded in 2014 to honor the life and legacy of Dr. Kevin Lederer, a well-respected and beloved physician who specialized in reproductive endocrinology and infertility. The Life Foundation aims to promote health and alleviate the mental and physical distress of individuals and couples diagnosed with infertility by hosting educational events and providing financial assistance through the Life Grant program. To learn more visit www.lifefindsaway.org.
Media Contact: Janna Miller [email protected] 720.381.4159


Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



